SMAD2 and acute lymphoblastic leukemia: Our functional studies involving SMAD2/3 phosphorylation analysis and cell proliferation assays suggest that the examined BCP-ALL cell lines retain at least partial responsiveness to TGF-β1 cytostatic effects.